American International Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,669
Closed -$38K 3254
2022
Q1
$38K Sell
12,669
-892
-7% -$3.02K ﹤0.01% 2928
2021
Q4
$60K Sell
13,561
-406
-3% -$1.99K ﹤0.01% 2906
2021
Q3
$92K Sell
13,967
-28
-0.2% -$269 ﹤0.01% 2833
2021
Q2
$224 Buy
+13,995
New +$193K ﹤0.01% 2438
2020
Q2
Sell
-7,897
Closed -$15K 3160
2020
Q1
$15K Sell
7,897
-457
-5% -$1.43K ﹤0.01% 2965
2019
Q4
$38K Buy
8,354
+77
+0.9% +$478 ﹤0.01% 2942
2019
Q3
$69K Sell
8,277
-58
-0.7% -$634 ﹤0.01% 2793
2019
Q2
$104K Buy
8,335
+204
+3% +$2.88K ﹤0.01% 2656
2019
Q1
$124K Buy
8,131
+3,927
+93% +$65K ﹤0.01% 2497
2018
Q4
$81K Sell
4,204
-31
-0.7% -$680 ﹤0.01% 2698
2018
Q3
$136K Buy
+4,235
New +$129K ﹤0.01% 2660

Other funds holding STIM

American International Group's STIM Position: Q2 2022 in Review

American International Group sold out of Neuronetics (STIM) in Q2 2022, closing a stake of 12,669 shares — an estimated $38K sold.

American International Group first reported a position in STIM in Q3 2018 and held it in 11 quarters. The position peaked at $136K in Q3 2018. 77 funds tracked by Wall St. Rank hold STIM as of Q2 2022.

  • American International Group reported no remaining Neuronetics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 12,669 Neuronetics shares in Q2 2022, an estimated $38K.
  • American International Group first reported a position in Neuronetics in Q3 2018 and held it in 11 quarters.
  • American International Group's Neuronetics position peaked at $136K in Q3 2018.
  • 77 funds tracked by Wall St. Rank held Neuronetics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.